Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2023 | Focal therapy for prostate cancer

Chi-Hang Yee • 8 Mar 2023
EAU 2023
Genitourinary Cancer Prostate Cancer

Chi-Hang Yee, MBBS, MD, FRCSEd(Urol), FHKAM(Surgery), The Chinese University of Hong Kong, Hong Kong, China, discusses focal therapy for prostate cancer, highlighting the importance and challenge of patient selection. This interview took place at the EAU congress in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Chi-Hang Yee

1:08
Robotic radical cystectomy vs open surgery for bladder cancer
Chi-Hang Yee • 8 Mar 2023
1:02
Robotic radical cystectomy in renal transplantations patient with invasive UC
Chi-Hang Yee • 8 Mar 2023
1:05
How does concomitant prostate cancer in bladder cancer patients affect treatment and prognosis?
Chi-Hang Yee • 8 Mar 2023
1:12
The risk of concomitant prostate cancer in bladder cancer patients going for radical cystectomy
Chi-Hang Yee • 8 Mar 2023

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals